Recall Record

Portage, MI, United States

Stryker Instruments Div. of Stryker Corporation recalls

12 recalls recorded since 2018, most recently on 15 June 2022. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls12
Ongoing (FDA)0
Terminated or completed12
Class I (FDA)0

Terminated Class II Medical devices

Recall started
15 June 2022
Terminated
5 April 2024
Reason
When scanning sponges out after a surgical procedure, an error may allow for a duplicate sponge to be counted without the prompt to make a case note and allowing the case to close. The software update will prevent the occurrence of this error.
Distribution
The products were distributed to the following US states: KS and ME.
Initiated
Voluntary: Firm initiated
Recall number
Z-1452-2022

Terminated Class II Medical devices

Recall started
16 October 2020
Terminated
22 June 2022
Reason
Potential for the inner bit to contain a crack, that may or may not be visible, which may lead to metal fragments entering the surgical site and/or delayed disengagment during use.
Distribution
Nationwide Foreign: Australia Brazil Canada Chile Colombia Hong Kong Italy Mexico Netherlands Netherlands New Zealand South Africa South Korea Spain Sweden Switzerland United Kingdom
Initiated
Voluntary: Firm initiated
Recall number
Z-0431-2021

Terminated Class II Medical devices

Recall started
26 March 2020
Terminated
15 July 2020
Reason
Due to a distribution error, product from the affected lot was shipped expired.
Distribution
International distribution the country of Canada.
Initiated
Voluntary: Firm initiated
Recall number
Z-1807-2020

Terminated Class II Medical devices

Recall started
22 January 2020
Terminated
29 January 2024
Reason
Some Canister Scanning Labels used to calibrate the Triton Canister System have a color variance. Based on a comprehensive analysis, blood loss estimates obtained using these Canister Scanning Labels may result in lower than expected results.
Distribution
US Nationwide
Initiated
Voluntary: Firm initiated
Recall number
Z-1402-2022

Terminated Class II Medical devices

Recall started
13 January 2020
Terminated
10 August 2021
Reason
Hairline fractures in a component could allow electrical current to arc out of the device, resulting in a burn to the patient and/or user.
Distribution
Domestic distribution nationwide. Foreign distribution to Netherlands and Australia.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1097-2020, Z-1099-2020, Z-1098-2020

Terminated Class II Medical devices

Recall started
6 November 2019
Terminated
19 November 2021
Reason
There is a potential for the cuff to leak air leading to a loss of vascular occlusion.
Distribution
Worldwide distributions - US Nationwide distributions in the states of AL, CD, HI, IA, ID, IN, KS, KY, MA, ME, MI, MN, MT, NC, NE, NH, NJ, NV, NY, OK, OR, PA, SC, SD, TN, VA, WI, WV, and WY. Countries of Argentina, Australia, Canada, and Netherlands.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0593-2020, Z-0592-2020

Terminated Class II Medical devices

Recall started
31 July 2019
Terminated
24 March 2021
Reason
Stryker C2 NerveMonitor's design and instructions may not optimally address usability issues related to the functionality of the device, which may result in use errors potentially causing or contributing to nerve injury.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0024-2020, Z-0023-2020

Terminated Class II Medical devices

Recall started
19 March 2019
Terminated
26 June 2020
Reason
During manufacture, packaging materials for a small portion of the lot may not have been properly positioned, resulting in a potential breach in sterility.
Distribution
US Nationwide in the states of: FL, GA, ID, KY, MA, MD, MN, NC, PA, UT, WA, and WI. The products were distributed to the following foreign countries: Canada, France, Italy, Netherlands.
Initiated
Voluntary: Firm initiated
Recall number
Z-1215-2019

Terminated Class III Medical devices

Recall started
4 December 2018
Terminated
11 March 2024
Reason
Gauss Surgical is updating the Instructions for Use (IFU) for our Triton Sponge System in order to clarify proper technique for handling sponges and the calibration placard.
Distribution
US Nationwide.
Initiated
Voluntary: Firm initiated
Recall number
Z-1394-2022

Terminated Class II Medical devices

Recall started
23 February 2018
Terminated
23 May 2019
Reason
Separation of material layers may occur, causing a potential risk of exposure to contaminants.
Distribution
US Nationwide and Ireland, Japan, South Korea, UK
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1505-2018, Z-1509-2018, Z-1510-2018, Z-1501-2018, Z-1508-2018, Z-1506-2018, Z-1504-2018, Z-1500-2018, Z-1502-2018, Z-1503-2018, Z-1507-2018

Terminated Class II Medical devices

Recall started
9 November 2017
Terminated
16 April 2019
Reason
Lack of sterility assurance as bioburden levels were found to be higher than internal acceptable rates.
Distribution
Distributed in all 50 U.S. States and the District of Columbia. Distributed in Australia, Argentina, Japan, Canada, Chile, Korea, Spain, France, Italy, Netherlands, and United Kingdom.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-1252-2018, Z-1255-2018, Z-1249-2018, Z-1247-2018, Z-1253-2018, Z-1254-2018, Z-1248-2018, Z-1245-2018, Z-1243-2018, Z-1250-2018, Z-1251-2018, Z-1246-2018 and 1 more

Terminated Class II Medical devices

Recall started
16 October 2017
Terminated
3 April 2019
Reason
Stryker Instruments and Stryker Leibinger GmbH & Co. KG are voluntarily recalling certain serial numbers Thoracic Pedicle Feelers that are used in conjunction with the Stryker¿ Navigation System because the settings on the machine were higher than intended. This change led to increased energy directed onto the tip of the Thoracic Pedicle Feeler which caused material degradation where the laser marks exist. There is the potential for the tip of the Thoracic Pedicle Feeler to break.
Distribution
International , US and US Govt.
Initiated
Voluntary: Firm initiated
Recall number
Z-1216-2018

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.